Skip to main content
Top
Published in: International Journal of Clinical Oncology 2/2011

01-04-2011 | Case Report

Spindle cell carcinoma of the nasal cavity

Authors: Tadashi Terada, Taiji Kawasaki

Published in: International Journal of Clinical Oncology | Issue 2/2011

Login to get access

Abstract

We report an extremely rare case of spindle cell carcinoma of the sinonasal cavity. A 75-year-old man was admitted to our hospital because of right nasal obstruction. Nasal endoscopy showed a polypoid tumor measuring 3 × 3 cm at the nasal septum in the right nasal cavity, and an excisional biopsy was performed. Computed tomography (CT) demonstrated the nasal tumor extended to the maxillary sinus. Histologically, the tumor consisted of malignant spindle cells with hyperchromatic nuclei. Mitotic figures and necrosis were recognized. In some areas, edematous changes were recognized. No apparent differentiation was noted. The tumor cells were free of keratinization and intercellular bridge formations; therefore, there were no squamous cell components. Immunohistochemically, the tumor cells were positive for pancytokeratin, cytokeratin (CK)5/6, CK18, CK19, high molecular weight CK, p63, and vimentin. The tumor cells were negative for epithelial membrane antigen, CK7, CK14, p53 protein, S100 protein, HMB45, chromogranin, synaptophysin, CD34, CD56, glial fibrillary acidic protein, neuron-specific enolase, neurofilaments, α-smooth muscle actin, neuroblastoma, myoglobin, carcinoembryonic antigen (CEA), carbohydrate antigen (CA)19-9, CD3, CD20, CD30, CD45RO, and CD45. A pathological diagnosis of spindle cell carcinoma of sinonasal lesion was made. The patient underwent resection of right maxilla followed by chemotherapy and radiation and was alive without metastasis 5 years after initial presentation.
Literature
1.
go back to reference Terada T, Kawaguchi M, Furukawa K et al (2002) Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int 52:740–746PubMedCrossRef Terada T, Kawaguchi M, Furukawa K et al (2002) Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int 52:740–746PubMedCrossRef
2.
go back to reference Terada T (2009) Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Pathol 28:29–34PubMedCrossRef Terada T (2009) Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Pathol 28:29–34PubMedCrossRef
3.
go back to reference Terada T (2009) Large endocervical polyp with cartilaginous and osseous metaplasia: a hitherto unreported entity. Int J Gynecol Pathol 28:98–100PubMedCrossRef Terada T (2009) Large endocervical polyp with cartilaginous and osseous metaplasia: a hitherto unreported entity. Int J Gynecol Pathol 28:98–100PubMedCrossRef
4.
go back to reference Olsen SH, Thomas DG, Lucas DR (2006) Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol 19:659–668PubMedCrossRef Olsen SH, Thomas DG, Lucas DR (2006) Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol 19:659–668PubMedCrossRef
5.
go back to reference Folpe AL, Schmidt RA, Chapman D et al (1998) Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 22:673–682PubMedCrossRef Folpe AL, Schmidt RA, Chapman D et al (1998) Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 22:673–682PubMedCrossRef
6.
go back to reference Yip YL, Tsao SW (2008) Regulation of p63 expression in primary and immortalized nasopharyngeal epithelial cells. Int J Oncol 33:713–724PubMed Yip YL, Tsao SW (2008) Regulation of p63 expression in primary and immortalized nasopharyngeal epithelial cells. Int J Oncol 33:713–724PubMed
7.
go back to reference Nylander K, Vojtesek B, Nenutil R et al (2002) Differential expression of p63 isoforms in normal tissue and neoplastic cells. J Pathol 198:417–427PubMedCrossRef Nylander K, Vojtesek B, Nenutil R et al (2002) Differential expression of p63 isoforms in normal tissue and neoplastic cells. J Pathol 198:417–427PubMedCrossRef
8.
go back to reference Minton TJ, Goyal P (2009) Endoscopic treatment of maxillary sinus spindle cell carcinoma. J Otolarungol Head Neck Surg 38:E45–E50 Minton TJ, Goyal P (2009) Endoscopic treatment of maxillary sinus spindle cell carcinoma. J Otolarungol Head Neck Surg 38:E45–E50
9.
go back to reference Howard SN, Bond WR, Hong IS et al (2007) Right maxillary sinus sarcomatoid Carcinoma (sarcomatoid/spindle cell carcinoma). Otolaryngol Head Neck Surg 137:355–357PubMedCrossRef Howard SN, Bond WR, Hong IS et al (2007) Right maxillary sinus sarcomatoid Carcinoma (sarcomatoid/spindle cell carcinoma). Otolaryngol Head Neck Surg 137:355–357PubMedCrossRef
10.
go back to reference Mills SE, Gaffey MJ, Frierson HF Jr (1997) Spindle cell carcinoma. In: Rosai J, Sobin LH (eds) Armed Forces Institute of Pathology Atlas of tumor pathology. Tumors of the upper aerodigestive trac and yeart, 3rd series. Armed Forces Institute of Pathology, Washington, DC, pp 76–80 Mills SE, Gaffey MJ, Frierson HF Jr (1997) Spindle cell carcinoma. In: Rosai J, Sobin LH (eds) Armed Forces Institute of Pathology Atlas of tumor pathology. Tumors of the upper aerodigestive trac and yeart, 3rd series. Armed Forces Institute of Pathology, Washington, DC, pp 76–80
11.
go back to reference Colby TV, Koss MN, Travis WD (1994) Squamous cell carcinoma and variants. In: Ropsai J, Sobin LH (eds) Armed Forces Institute of Pathology Atlas of tumor pathology. Tumors of the lower respiratory tract, 3rd series. Armed Forces Institute of Pathology, Washington, DC, pp 157–178 Colby TV, Koss MN, Travis WD (1994) Squamous cell carcinoma and variants. In: Ropsai J, Sobin LH (eds) Armed Forces Institute of Pathology Atlas of tumor pathology. Tumors of the lower respiratory tract, 3rd series. Armed Forces Institute of Pathology, Washington, DC, pp 157–178
12.
go back to reference Lewis JE, Olsen KD, Sebo TJ (1997) Spindle cell carcinoma of the larynx: review of 26 cases including DNA content and immunohistochemistry. Hum Pathol 28:664–673PubMedCrossRef Lewis JE, Olsen KD, Sebo TJ (1997) Spindle cell carcinoma of the larynx: review of 26 cases including DNA content and immunohistochemistry. Hum Pathol 28:664–673PubMedCrossRef
13.
go back to reference Rosai J (2004) Respiratory tract. In: Roai J (ed) Rosai and Ackerman’s surgical pathology, 9th edn. St. Louis, Mosby, pp 305–334 Rosai J (2004) Respiratory tract. In: Roai J (ed) Rosai and Ackerman’s surgical pathology, 9th edn. St. Louis, Mosby, pp 305–334
14.
go back to reference Corrin B, Wick MR, Chang YL (2004) Sarcomatoid carcinoma. In: Travis D, Brambillia E, Muller-Hermelink K, Harris CC et al (eds) World Health Organization classification of tumours. Pathology and genetics. Tumor of the lung, pleura, thymus and heart. IARC press, Lyon, pp 53–58 Corrin B, Wick MR, Chang YL (2004) Sarcomatoid carcinoma. In: Travis D, Brambillia E, Muller-Hermelink K, Harris CC et al (eds) World Health Organization classification of tumours. Pathology and genetics. Tumor of the lung, pleura, thymus and heart. IARC press, Lyon, pp 53–58
Metadata
Title
Spindle cell carcinoma of the nasal cavity
Authors
Tadashi Terada
Taiji Kawasaki
Publication date
01-04-2011
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2011
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0121-2

Other articles of this Issue 2/2011

International Journal of Clinical Oncology 2/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine